Editorial: Get ready for the genomic revolution

Prostate cancer is a recognised component of the hereditary breast and ovarian cancer (HBOC) syndrome cancer spectrum, where inherited susceptibility is accounted for by mutations in BRCA1 and BRCA2 genes. Genetic testing for BRCA1/2 mutations may provide some men with information about their risk for developing aggressive prostate cancer.

Read the full article

Add yours ↓
Web design and marketing agency Leamington Spa